Basma Adeem Medical Co.

Basma Adeem Medical Co.

TTADAWUL:9626
6.70
SAR
+0.48
(+7.72%)
125.00MMarket Cap
Basma Adeem Medical Co.
TADAWUL:9626
(Saudi Exchange)

Recent

price

6.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2024
2025
TTM
SAR
1.7
2.52
- -
Revenue per Share
0.32
0.4
- -
Basic EPS, GAAP
0.4
0.63
- -
Free Cash Flow per Basic Share
- -
- -
- -
Dividend per Share
1.12
1.8
2.54
Book Value per Share
1.12
1.8
2.54
Tangible Book Value per Share
20
18
19
Basic Weighted Avg Shares
34
45
- -
Sales/Revenue/Turnover
20.55
17.78
- -
Operating Margin (%)
- -
- -
- -
Depreciation Expense
6
7
- -
Net Income, GAAP
7.11
11.45
- -
Effective Tax Rate (%)
18.58
16.07
- -
Profit Margin (%)
18
36
37
Working Capital
- -
- -
19
LT Debt
22
36
51
Total Equity
- -
24.51
- -
Return on Invested Capital (%)
- -
27.38
- -
Return on Capital (%)
- -
25.02
- -
Return on Common Equity (%)

Capital Structure

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
3
- -
2
LT Borrowings
- -
- -
- -
LT Finance Leases
10
- -
19
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
97
112
125

Working Capital

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
38
43
44
Cash, Cash Equivalents & STI
35
39
39
Accounts Receivable, Net
- -
- -
- -
Inventories
1
- -
1
Total Current Liabilities
6
7
7
Payables & Accruals
- -
- -
- -
ST Debt
3
- -
2
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
61.69%
Free Cash Flow
- -
- -
42.49%
Net Income, GAAP
- -
- -
15.93%
Sales/Revenue/Turnover
- -
- -
34.02%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
34
2025
- -
- -
45
2026
- -
- -
- -

Semi-annual Earnings Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.32
2025
- -
- -
0.4
2026
- -
- -
- -

Semi-annual Dividends Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Basma Adeem Medical Co. (9626.SR), doing business as Smile Care, provides dental and dermatology services in Saudi Arabia; its core offerings encompass one-day surgery, orthodontics and maxillofacial surgery, periodontal surgery and dental implants, root canal treatments and endodontics, oral and dental health care, dental repair and cosmetic dentistry, prosthodontics, pediatric dentistry, preventive restorations, oral surgery, laser treatments for skin conditions, teeth whitening, veneers, gum depigmentation, dental scaling, fillings, and clear aligners. The company operates specialized clinics targeting patients seeking comprehensive oral health, cosmetic enhancements, and dermatological solutions, with a focus on high-quality preventive and corrective treatments delivered by experienced Saudi and international specialists. Founded on November 13, 2012, and headquartered on King Abdulaziz Branch Road in Al Yasmeen District, Riyadh, Basma Adeem Medical Co. serves the Kingdom's healthcare market through multiple branches. In recent developments, the company listed on the Nomu parallel market of the Saudi Stock Exchange on February 3, 2025, at SAR 4.40 per share, raising funds through its initial public offering; it opened a second dental clinic in Riyadh in July 2025, secured a SAR 3.87 million contract with the King Abdullah Financial District (KAFD) in August 2025, and obtained a Health Ministry license for its dermatology department at the Riyadh branch in October 2025. These expansions support ongoing profit growth, including a 7.3% rise to SAR 2.6 million in H1 2025 and 29% to SAR 6.3 million for full-year 2024.